Plandai Financial Statements From 2010 to 2025
Plandai Biotech's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Plandai Biotech's valuation are provided below:Plandai Biotech does not presently have any trending fundamental ratios for analysis.
This module can also supplement various Plandai Biotech Technical models . Check out the analysis of Plandai Biotech Correlation against competitors.
Check Plandai Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Plandai Biotech's main balance sheet or income statement drivers, such as , as well as many indicators such as . Plandai financial statements analysis is a perfect complement when working with Plandai Biotech Valuation or Volatility modules.
Plandai |
Plandai Biotech Company Return On Asset Analysis
Plandai Biotech's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Plandai Biotech Return On Asset | -0.21 |
Most of Plandai Biotech's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Plandai Biotech is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Plandai Biotech has a Return On Asset of -0.2096. This is 55.4% lower than that of the Biotechnology sector and significantly lower than that of the Health Care industry. The return on asset for all United States stocks is 49.71% higher than that of the company.
Plandai Biotech Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Plandai Biotech's current stock value. Our valuation model uses many indicators to compare Plandai Biotech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Plandai Biotech competition to find correlations between indicators driving Plandai Biotech's intrinsic value. More Info.Plandai Biotech is considered to be number one stock in return on asset category among its peers. It also is considered to be number one stock in operating margin category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Plandai Biotech's earnings, one of the primary drivers of an investment's value.About Plandai Biotech Financial Statements
Plandai Biotech investors utilize fundamental indicators, such as revenue or net income, to predict how Plandai Pink Sheet might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Planda Biotechnology, Inc. focuses on the production of proprietary botanical extracts for the nutriceutical and pharmaceutical industries. Planda Biotechnology, Inc. is based in London, the United Kingdom. Diamond Ranch is traded on OTC Exchange in the United States.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetOther Information on Investing in Plandai Pink Sheet
Plandai Biotech financial ratios help investors to determine whether Plandai Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Plandai with respect to the benefits of owning Plandai Biotech security.